Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2021-04-14 Gift | 2022-04-15 7:14 pm | N/A N/A | Sana Biotechnology Inc. | SANA | Harr Steve President & CEO | 167,000 | $0 | 8,856,250 (Direct) | View |
| 2022-03-03 Option Award | 2022-03-08 09:08 am | N/A 2032-03-02 | Sana Biotechnology Inc. | SANA | Harr Steve President & CEO | 760,000 | $0 | 760,000 (Direct) | View |
| 2021-02-08 Conversion | 2021-02-10 6:53 pm | N/A N/A | Sana Biotechnology Inc. | SANA | Harr Steve President & CEO | 4,062,500 | $0 | 8,856,250 (Direct) | View |
| 2021-02-03 Ownership | 2021-02-03 9:06 pm | N/A N/A | Sana Biotechnology Inc. | SANA | Harr Steve President & CEO | 0 | $0 | 10,564,973 (Direct) | View |
| 2019-02-15 Disposition | 2019-02-15 09:13 am | N/A 2026-11-06 | Loxo Oncology Inc. | LOXO | Harr Steve Director | 35,375 | $235 | 0 (Direct) | View |
| 2018-06-13 Option Award | 2018-06-14 5:04 pm | N/A 2028-06-12 | Loxo Oncology Inc. | LOXO | Harr Steve Director | 8,750 | $0 | 8,750 (Direct) | View |
| 2018-03-05 Disposition | 2018-03-07 6:20 pm | N/A N/A | Juno Therapeutics Inc. | JUNO | Harr Steve CFO & Head Corp. Development | 50,010 | $87 | 0 (Direct) | View |
| 2018-03-05 Equity Swap | 2018-03-07 6:20 pm | N/A N/A | Juno Therapeutics Inc. | JUNO | Harr Steve CFO & Head Corp. Development | 492,355 | $87 | 0 (Direct) | View |
| 2018-03-05 Disposition | 2018-03-07 6:20 pm | N/A 2024-11-13 | Juno Therapeutics Inc. | JUNO | Harr Steve CFO & Head Corp. Development | 563,743 | $0 | 0 (Direct) | View |
| 2018-02-27 Option Award | 2018-03-01 6:23 pm | N/A N/A | Juno Therapeutics Inc. | JUNO | Harr Steve CFO & Head Corp. Development | 11,544 | $0 | 639,517 (Direct) | View |